Literature DB >> 8241846

Antiphospholipid syndrome.

M Khamashta, G R Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8241846      PMCID： PMC1679033          DOI： 10.1136/bmj.307.6909.883

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

Authors:  F S Cowchock; E A Reece; D Balaban; D W Branch; L Plouffe
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

2.  Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both?

Authors:  J T Lie
Journal:  J Rheumatol       Date:  1989-06       Impact factor: 4.666

3.  Antiphospholipid antibodies in cerebral ischemia.

Authors:  J Montalbán; A Codina; J Ordi; M Vilardell; M A Khamashta; G R Hughes
Journal:  Stroke       Date:  1991-06       Impact factor: 7.914

4.  Low-dose aspirin in pregnancy.

Authors:  M G Elder; M de Swiet; A Robertson; M A Elder; E Flloyd; D F Hawkins
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

Review 5.  The antiphospholipid syndrome: ten years on.

Authors:  G R Hughes
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

6.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

7.  Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Authors:  M H Rosove; P M Brewer
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

8.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

Authors:  H P McNeil; R J Simpson; C N Chesterman; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  J S Ginsberg; P Brill-Edwards; M Johnston; J A Denburg; M Andrew; R F Burrows; W Bensen; A Cividino; A A Long
Journal:  Blood       Date:  1992-08-15       Impact factor: 22.113

10.  Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

Authors:  A J Weiner; G Kuo; D W Bradley; F Bonino; G Saracco; C Lee; J Rosenblatt; Q L Choo; M Houghton
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321
View more
  5 in total

1.  Recognizing antiphospholipid syndrome. Case report: misdiagnosis delayed treatment.

Authors:  P Kirk; J A Moran
Journal:  Can Fam Physician       Date:  1996-02       Impact factor: 3.275

2.  Guidelines for the management of thrombophilia. Department of Haematology, The Royal London Hospital, Whitechapel, London, UK.

Authors:  J D Cavenagh; B T Colvin
Journal:  Postgrad Med J       Date:  1996-02       Impact factor: 2.401

Review 3.  Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Authors:  M A Khamashta; G R Hughes
Journal:  Clin Rev Allergy       Date:  1994

Review 4.  Cardiolipin, coagulation, co-factors and connective tissue disease.

Authors:  R S Pereira
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

5.  Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.

Authors:  C Sachse; K Lüthke; K Hartung; M Fricke; B Liedvogel; J R Kalden; H H Peter; H J Lakomek; E Henkel; H Deicher
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.